January 15, 2020

WuXi Global Forum 2020

Date and time

January 14, 2020 ~ January 14, 2020

Now in its eighth year, the WuXi Global Forum at the J.P. Morgan Healthcare Conference brings together thousands of leaders to promote new thinking on a global stage as we strive to provide transformative solutions for patients.

Agenda

01:00 PM - 01:30 PM REGISTRATION and NETWORKING
REGISTRATION and NETWORKING
01:30 PM - 01:35 PM WELCOME
Hui Cai, Forum Chair, VP and Head of Content Division, WuXi AppTec
01:35 PM - 01:45 PM OPENING REMARKS
Ge Li, Chairman, WuXi AppTec and WuXi Biologics
01:45 PM - 02:50 PM SESSION I: STATE OF INNOVATION
Are We Breaking New Ground?
David Schenkein, General Partner, GV
Antoine Papiernik, Managing Partner, Sofinnova Partners
Kristiina Vuori, President, Sanford Burnham Prebys Medical Discovery Institute
Edward Hu, Co-CEO, WuXi AppTec
Moderator: Eric Elenko, Chief Innovation Officer, PureTech Health

A Dialogue with Howard “Skip” Burris, President, ASCO; President of Clinical Operations and CMO, Sarah Cannon
Moderator: Fred Hausheer, Global Chief Medical Officer and Head of WuXi Oncology, WuXi AppTec
02:50 PM - 03:50 PM SESSION II: SPOTLIGHT ON CELL AND GENE THERAPIES
Cell Therapies: Where Are We Heading?
Richard Klausner, Founder and CEO, Lyell Immunopharma
Patrick Hwu, Head, Division of Cancer Medicine, MD Anderson Cancer Center
Moderator: Karen Bernstein, Co-Founder and Chairman, BioCentury

Delivering the Promise of Gene Therapies
James Wilson, Professor of Medicine and Pediatrics of Department of Medicine and Director of Gene Therapy Program, University of Pennsylvania
Tachi Yamada, Venture Partner, Frazier Healthcare Partners
Moderator: John Carroll, Editor and Founder, Endpoints News
03:50 PM - 04:55 PM SESSION III: RACE TO THE CURE
A Dialogue with David Liu, Director of the Merkin Institute and Vice-Chair of the Faculty, Broad Institute; Professor of Harvard University and HHMI
Moderator: Chris Chen, CEO, WuXi Biologics

Incremental or Transformative?
Paul-Peter Tak, President and CEO, Kintai Therapeutics
Steve Paul, Chairman and CEO, Karuna Therapeutics
Samantha Du, Chairman and CEO, Zai Lab
Lalo Flores, CEO, Century Therapeutics
Moderator: Steve Yang, EVP and CBO, WuXi AppTec
04:55 PM - 06:00 PM SESSION IV: INNOVATION 2030
A Dialogue with Hans Bishop, CEO, GRAIL
Moderator: Melinda Richter, Global Head, Johnson & Johnson Innovation, JLABS

How is Technology Shaping the Future of Healthcare?
Jason Coloma, President and CEO, Maze Therapeutics
Zavain Dar, Partner, Lux Capital
Carolyn Magill, CEO, Aetion
John Halamka, President, Mayo Clinic Platform
Leon Wang, Executive VP International and China President, AstraZeneca
Moderator: Kenneth Kaitin, Professor and Director, Tufts Center for the Study of Drug Development, Tufts University School of Medicine
06:00 PM - 06:10 PM CLOSING REMARKS
Steve Bates, CEO, UK BioIndustry Association
06:10 PM - 07:00 PM RECEPTION

Speakers

Hui Cai
FORUM CHAIR, VP AND HEAD OF CONTENT DIVISION, WUXI APPTEC
Ge Li
FOUNDER, CHAIRMAN AND CEO OF WUXI APPTEC FOUNDER AND CHAIRMAN OF WUXI BIOLOGICS
Eric Elenko
CHIEF INNOVATION OFFICER, PURETECH HEALTH
David Schenkein
David Schenkein
Antoine Papiernik
MANAGING PARTNER, SOFINNOVA PARTNERS
Kristiina Vuori
PRESIDENT, SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
Fred Hausheer
GLOBAL CHIEF MEDICAL OFFICER AND HEAD OF WUXI ONCOLOGY, WUXI APPTEC
Edward Hu
CO-CEO, WUXI APPTEC
Howard “Skip” Burris
PRESIDENT, ASCO; PRESIDENT OF CLINICAL OPERATIONS AND CMO, SARAH CANNON
Karen Bernstein
CO-FOUNDER AND CHAIRMAN, BIOCENTURY
Richard Klausner
FOUNDER AND CEO, LYELL IMMUNOPHARMA
Patrick Hwu
HEAD, DIVISION OF CANCER MEDICINE, MD ANDERSON CANCER CENTER
John Carroll
EDITOR AND FOUNDER, ENDPOINTS NEWS
James M. Wilson
PROFESSOR OF MEDICINE AND PEDIATRICS OF DEPARTMENT OF MEDICINE AND DIRECTOR OF GENE THERAPY PROGRAM, UNIVERSITY OF PENNSYLVANIA
Tachi Yamada
VENTURE PARTNER, FRAZIER HEALTHCARE PARTNERS
Chris Chen
CEO, WUXI BIOLOGICS
David Liu
DIRECTOR OF THE MERKIN INSTITUTE AND VICE-CHAIR OF THE FACULTY, BROAD INSTITUTE PROFESSOR OF HARVARD UNIVERSITY AND HHMI
Steve Yang
EVP AND CBO, WUXI APPTEC
Paul-Peter Tak
PRESIDENT AND CEO, KINTAI THERAPEUTICS
Steve Paul
CHAIRMAN AND CEO, KARUNA THERAPEUTICS
Samantha Du
CHAIRMAN AND CEO, ZAI LAB
Osvaldo (Lalo) Flores
CEO, CENTURY THERAPEUTICS
Melinda Richter
GLOBAL HEAD, JOHNSON & JOHNSON INNOVATION, JLABS
Hans Bishop
CEO, GRAIL
Kenneth Kaitin
PROFESSOR AND DIRECTOR, TUFTS CENTER FOR THE STUDY OF DRUG DEVELOPMENT, TUFTS UNIVERSITY SCHOOL OF MEDICINE
Jason Coloma
PRESIDENT AND CEO, MAZE THERAPEUTICS
Zavain Dar
PARTNER, LUX CAPITAL
Carolyn Magill
CEO, AETION
John D. Halamka
PRESIDENT, MAYO CLINIC PLATFORM
Leon Wang
EXECUTIVE VP INTERNATIONAL AND CHINA PRESIDENT, ASTRAZENECA
Steve Bates
CEO, UK BIOINDUSTRY ASSOCIATION